| |
Vulnerability CVE-2015-3965
Published: 2019-03-23 Modified: 2019-03-24
| Description: |
Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger "unanticipated operations" by leveraging "elevated privileges" for an unspecified call to an incorrectly exposed function. |
Type:
CWE-264 (Permissions, Privileges, and Access Controls)
CVSS2 => (AV:N/AC:L/Au:S/C:C/I:C/A:C)
| CVSS Base Score |
Impact Subscore |
Exploitability Subscore |
9/10 |
10/10 |
8/10 |
| Exploit range |
Attack complexity |
Authentication |
Remote |
Low |
Single time |
| Confidentiality impact |
Integrity impact |
Availability impact |
Complete |
Complete |
Complete |
References: |
https://ics-cert.us-cert.gov/advisories/ICSA-15-174-01
|
|
|
Copyright 2024, cxsecurity.com
|
|
|
